According to LabCorp's latest financial reports and stock price the company's current Operating Margin is 10.63%. At the end of 2022 the company had an Operating Margin of 10.64%.
Year | Operating Margin | Change |
---|---|---|
2022 | 10.64% | -45.15% |
2021 | 19.39% | 22.17% |
2020 | 15.88% | 66.02% |
2019 | 9.56% | -14.55% |
2018 | 11.19% | 2.96% |
2017 | 10.87% | -5.2% |
2016 | 11.47% | 35.94% |
2015 | 8.43% | -38.67% |
2014 | 13.75% | -12.76% |
2013 | 15.76% | -5.31% |
2012 | 16.65% | 6.54% |
2011 | 15.63% | -14.6% |
2010 | 18.30% | -2.89% |
2009 | 18.84% | 9.9% |
2008 | 17.14% | -13.07% |
2007 | 19.72% | -1.77% |
2006 | 20.08% | 4.27% |
2005 | 19.25% | -3.47% |
2004 | 19.95% | 8.49% |
2003 | 18.38% | 6.65% |
2002 | 17.24% | 14.12% |
2001 | 15.11% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
IDEXX Laboratories IDXX | 25.53% | 140.17% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | 11.10% | 4.42% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | 18.52% | 74.20% | ๐บ๐ธ USA |
NeoGenomics
NEO | -31.26% | -394.07% | ๐บ๐ธ USA |
Qiagen QGEN | 23.93% | 125.12% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | -43.44% | -508.65% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.